TN2014000184A1 - N- (3- { [ (3- { [2-chloro-5- (methoxy) phenyl] amino} quinoxalin- 2 -yl) amino] sulfonyl} phe nyl) - 2 -methylalaninamide as phosphatidylinositol 3 - kinase inhibitor for the treatment of lymphoproliferative malignancies - Google Patents

N- (3- { [ (3- { [2-chloro-5- (methoxy) phenyl] amino} quinoxalin- 2 -yl) amino] sulfonyl} phe nyl) - 2 -methylalaninamide as phosphatidylinositol 3 - kinase inhibitor for the treatment of lymphoproliferative malignancies

Info

Publication number
TN2014000184A1
TN2014000184A1 TNP2014000184A TN2014000184A TN2014000184A1 TN 2014000184 A1 TN2014000184 A1 TN 2014000184A1 TN P2014000184 A TNP2014000184 A TN P2014000184A TN 2014000184 A TN2014000184 A TN 2014000184A TN 2014000184 A1 TN2014000184 A1 TN 2014000184A1
Authority
TN
Tunisia
Prior art keywords
amino
treatment
methylalaninamide
quinoxalin
phosphatidylinositol
Prior art date
Application number
TNP2014000184A
Inventor
Arthur Decillis
Joanne Lager
Original Assignee
Sanofi Sa
Exelixis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/062999 external-priority patent/WO2013067141A1/en
Application filed by Sanofi Sa, Exelixis Inc filed Critical Sanofi Sa
Publication of TN2014000184A1 publication Critical patent/TN2014000184A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Methods are provided for treating breast cancer to a patient in need of such treatment, comprising administering a compound of formula la as described herein.
TNP2014000184A 2011-12-08 2014-04-30 N- (3- { [ (3- { [2-chloro-5- (methoxy) phenyl] amino} quinoxalin- 2 -yl) amino] sulfonyl} phe nyl) - 2 -methylalaninamide as phosphatidylinositol 3 - kinase inhibitor for the treatment of lymphoproliferative malignancies TN2014000184A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161568189P 2011-12-08 2011-12-08
PCT/US2012/062999 WO2013067141A1 (en) 2011-11-01 2012-11-01 N- (3- { [ (3- { [2-chloro-5- (methoxy) phenyl] amino} quinoxalin- 2 -yl) amino] sulfonyl} phe nyl) - 2 -methylalaninamide as phosphatidylinositol 3 - kinase inhibitor for the treatment of lymphoproliferative malignancies

Publications (1)

Publication Number Publication Date
TN2014000184A1 true TN2014000184A1 (en) 2015-09-30

Family

ID=59799096

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2014000184A TN2014000184A1 (en) 2011-12-08 2014-04-30 N- (3- { [ (3- { [2-chloro-5- (methoxy) phenyl] amino} quinoxalin- 2 -yl) amino] sulfonyl} phe nyl) - 2 -methylalaninamide as phosphatidylinositol 3 - kinase inhibitor for the treatment of lymphoproliferative malignancies

Country Status (1)

Country Link
TN (1) TN2014000184A1 (en)

Similar Documents

Publication Publication Date Title
MX341732B (en) Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use.
UA111382C2 (en) Protein kinase inhibitors
EA201100971A1 (en) DERIVATIVES OF PYRIMIDININDOL FOR THE TREATMENT OF MALIGNANT NORMALIZATION
AU2012324805A8 (en) (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
MX2014004429A (en) (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors.
NZ708382A (en) Cycloalkyl bis-thiadiazole inhibitors of glutaminase and their use as therapeutic agents
NZ626618A (en) Hydroxamic acid derivatives and uses thereof
UA110943C2 (en) N-acyl sulfonamideapoptosis promoters
GEP201606532B (en) Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
MY165087A (en) Neprilysin inhibitors
NZ615270A (en) Phosphoramidate derivatives of 5 - fluoro - 2 ‘ - deoxyuridine for use in the treatment of cancer
MY185103A (en) Bezylamine derivatives as inhibitors of plasma kallikrein
EA201391390A1 (en) CYCLOPROPYLAMINES AS LSD INHIBITORS
EA201490493A1 (en) PIRANO [3,2-D] [1,3] TIAZOLE AS GLYOZIDASE INHIBITORS
MX352975B (en) Pyridine-and pyrazine derivatives.
EA201170617A1 (en) PYRAZOLYLAMINOPIRIDINE AS FAK INHIBITORS
MX2011011733A (en) Dihydroorotate - dehydrogenasee inhibitors as virostatic compounds.
MX2012007582A (en) 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds.
MX2013008340A (en) Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer.
MX351863B (en) Quinolylpyrrolopyrimidyl fused-ring compound or salt thereof.
NZ602710A (en) Use of novel pan-cdk inhibitors for treating tumors
MX2014005249A (en) N- (3- { [ (3- { [2-chloro-5- (methoxy) phenyl] amino} quinoxalin- 2 -yl) amino] sulfonyl} phe nyl) - 2 -methylalaninamide as phosphatidylinositol 3 - kinase inhibitor for the treatment of lymphoproliferative malignancies.
MX348758B (en) Sanglifehrin derivatives and methods for their production.
UA117809C2 (en) BENDAMOUSTINE DERIVATIVES, RELATED COMPOUNDS AND THEIR MEDICAL APPLICATION FOR CANCER TREATMENT
TN2014000184A1 (en) N- (3- { [ (3- { [2-chloro-5- (methoxy) phenyl] amino} quinoxalin- 2 -yl) amino] sulfonyl} phe nyl) - 2 -methylalaninamide as phosphatidylinositol 3 - kinase inhibitor for the treatment of lymphoproliferative malignancies